Surgical & Medical Instruments & Apparatus · DE · CIK 1127537
Provides minimally invasive treatments for severe emphysema patients using the Zephyr Valve and related systems
Comparable business profile · signals at a glance
In the 90 days to Mar 2, 2026: 5 sold $187K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 2, 2026 | French Glendon E. IiiPresident and CEO | Sell | 58,368 | $1.43 | $83K |
| Mar 2, 2026 | French Glendon E. IiiPresident and CEO | Sell | 6,737 | $1.43 | $10K |
| Mar 2, 2026 | Lehman David AaronGENERAL COUNSEL | Sell | 4,433 | $1.43 | $6K |
| Mar 2, 2026 | Radhakrishnan SrikanthChief Science &Techn. Officer | Sell | 4,198 | $1.43 | $6K |
| Mar 2, 2026 | Lehman David AaronGENERAL COUNSEL | Sell | 4,051 | $1.43 | $6K |
| Mar 2, 2026 | Radhakrishnan SrikanthChief Science &Techn. Officer | Sell | 3,068 | $1.43 | $4K |
| Mar 2, 2026 | Rose Geoffrey BeranCHIEF COMMERCIAL OFFICER | Sell | 2,911 | $1.43 | $4K |
| Mar 2, 2026 | French Glendon E. IiiPresident and CEO | Sell | 2,708 | $1.43 | $4K |
| Mar 2, 2026 | Lehman David AaronGENERAL COUNSEL | Sell | 2,590 | $1.43 | $4K |
| Mar 2, 2026 | Radhakrishnan SrikanthChief Science &Techn. Officer | Sell | 2,461 | $1.43 | $4K |
| Mar 2, 2026 | Rose Geoffrey BeranCHIEF COMMERCIAL OFFICER | Sell | 2,125 | $1.43 | $3K |
| Mar 2, 2026 | Rose Geoffrey BeranCHIEF COMMERCIAL OFFICER | Sell | 1,861 | $1.43 | $3K |
| Mar 2, 2026 | Lehman David AaronGENERAL COUNSEL | Sell | 1,163 | $1.43 | $2K |
| Mar 2, 2026 | Rose Geoffrey BeranCHIEF COMMERCIAL OFFICER | Sell | 835 | $1.43 | $1K |
| Mar 2, 2026 | Radhakrishnan SrikanthChief Science &Techn. Officer | Sell | 756 | $1.43 | $1K |
| Dec 8, 2025 | Florin Daniel PDirector | Sell | 23,321 | $1.99 | $46K |
| Dec 1, 2025 | French Glendon E. IiiPresident and CEO | Sell | 6,281 | $1.57 | $10K |
| Dec 1, 2025 | Lehman David AaronGENERAL COUNSEL | Sell | 3,725 | $1.57 | $6K |
| Dec 1, 2025 | Lehman David AaronGENERAL COUNSEL | Sell | 3,401 | $1.57 | $5K |
| Dec 1, 2025 | French Glendon E. IiiPresident and CEO | Sell | 2,524 | $1.57 | $4K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.